GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hemant Surgical Industries Ltd (BOM:543916) » Definitions » Cash Flow from Financing

Hemant Surgical Industries (BOM:543916) Cash Flow from Financing : ₹24 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hemant Surgical Industries Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2024, Hemant Surgical Industries paid ₹0 Mil more to buy back shares than it received from issuing new shares. It received ₹60 Mil from issuing more debt. It paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ₹0 Mil from paying cash dividends to shareholders. It spent ₹8 Mil on other financial activities. In all, Hemant Surgical Industries earned ₹52 Mil on financial activities for the six months ended in Sep. 2024.


Hemant Surgical Industries Cash Flow from Financing Historical Data

The historical data trend for Hemant Surgical Industries's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemant Surgical Industries Cash Flow from Financing Chart

Hemant Surgical Industries Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Cash Flow from Financing
5.17 -77.01 -6.99 212.40

Hemant Surgical Industries Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial - - 240.88 -28.48 52.10

Hemant Surgical Industries Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Hemant Surgical Industries's Cash from Financing for the fiscal year that ended in Mar. 2024 is calculated as:

Hemant Surgical Industries's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemant Surgical Industries  (BOM:543916) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Hemant Surgical Industries's issuance of stock for the six months ended in Sep. 2024 was ₹0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Hemant Surgical Industries's repurchase of stock for the six months ended in Sep. 2024 was ₹0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Hemant Surgical Industries's net issuance of debt for the six months ended in Sep. 2024 was ₹60 Mil. Hemant Surgical Industries received ₹60 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Hemant Surgical Industries's net issuance of preferred for the six months ended in Sep. 2024 was ₹0 Mil. Hemant Surgical Industries paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Hemant Surgical Industries's cash flow for dividends for the six months ended in Sep. 2024 was ₹0 Mil. Hemant Surgical Industries received ₹0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Hemant Surgical Industries's other financing for the six months ended in Sep. 2024 was ₹-8 Mil. Hemant Surgical Industries spent ₹8 Mil on other financial activities.


Hemant Surgical Industries Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Hemant Surgical Industries's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemant Surgical Industries Business Description

Traded in Other Exchanges
N/A
Address
J.S.D. Road, 502, 5th Floor, Ecstasy Business Park, Co-Op Society Limited, Mulund West, Mumbai, MH, IND, 400 080
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.

Hemant Surgical Industries Headlines

No Headlines